Medical Devices News and Research

RSS

MRCC deploys CTT's Calmare Pain Therapy Treatment medical device

Competitive Technologies, Inc. announced that McKinney Regional Cancer Care Center, a private physician oncology practice based in McKinney, TX, is the first cancer center in Texas treating with CTT's Calmare Pain Therapy Treatment medical device. Patients suffering from pain related to cancer are being treated under the direction of medical oncologist Dennis Birenbaum, M.D.

3 Aug 2010

Allergan second-quarter diluted EPS increases to $0.78

Allergan, Inc. today announced operating results for the quarter ended June 30, 2010. Allergan also announced that its Board of Directors has declared a second quarter dividend of $0.05 per share, payable on September 7, 2010 to stockholders of record on August 17, 2010.

3 Aug 2010

RoundTable announces establishment of new platform business in ophthalmology market

RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has established a platform business in the ophthalmology market. The new platform company, Beaver-Visitec International, Inc., consists of ophthalmology products and assets recently acquired from BD and Medtronic, Inc.

2 Aug 2010

WellDoc DiabetesManager System receives FDA clearance

WellDoc, a healthcare company that develops technology solutions to improve chronic disease management outcomes and reduce healthcare costs, today announced that it has received United States Food and Drug Administration 510(k) clearance to market the WellDoc DiabetesManager System to healthcare providers and their adult patients with type 2 diabetes.

2 Aug 2010

Teleflex receives forty-one approvals for certificates to foreign governments from FDA

Teleflex Incorporated today announced that it has received approval of a significant number of additional certificates to foreign governments ("CFG") from the FDA, totaling forty-one approvals out of eighty-five submitted requests.

2 Aug 2010

GRS announces Martin as European General Manager, Executive Vice President of Global Development

Global Research Services, LLC (GRS), an international cardiovascular clinical research organization (CRO) serving pharmaceutical, biotech and medical device companies with comprehensive clinical trial management services, announced today that Benoît Martin, a seasoned executive with more than a decade of leading international CRO business units, has been named as the European General Manager and Executive Vice President of Global Development.

2 Aug 2010

Active ingredients continue to attract new, loyal investors

Active ingredients ranging from weight-loss herbals to cancer-killing cytotoxics attract billions in venture investment dollars every year. But technologies designed to selectively deliver active ingredients to targeted locations are beginning to gain momentum, as their application in drugs, medical devices, food, personal care, and agricultural chemicals rapidly grows and corporate venture investors take notice, according to a new report from Lux Research.

31 Jul 2010

GHX Market Intelligence data increases growth of medical-surgical revenue through distribution by 6.42% in 2009

An analysis of medical-surgical sales through distribution conducted by GHX has found that among the top 100 U.S. medical-surgical manufacturers by dollar spend, those that use GHX Market Intelligence data grew medical-surgical revenue through distribution by an average of 6.42 percent in 2009, while non-users grew similarly classified revenue by an average of only 3.88 percent. Furthermore, GHX's analysis also found that those manufacturers employing more granular-level market data from GHX increased revenue at a faster rate than those using higher-level data.

31 Jul 2010

Angiotech reports $61.9 million total revenue for second-quarter 2010

Angiotech Pharmaceuticals, Inc. today announced its financial results for the second quarter ended June 30, 2010.

31 Jul 2010

BioSpace launches 2010 BioMidwest Hotbed Campaign

BioSpace added Kansas to its annual promotional campaign of biotechnological, pharmaceutical and medical device companies from Nebraska to Ohio.

31 Jul 2010

Commonwealth Pain Specialists offers treatment with CTT's Calmare Pain Therapy device

Competitive Technologies, Inc. announced today that Commonwealth Pain Specialists, the premier pain management center in Richmond and Central Virginia, is treating patients suffering from chronic, intense neuropathic pain using CTT's Calmare® Pain Therapy medical device.

31 Jul 2010

Poll: Many Americans not sure of provisions of new healthcare legislation

Not sure what's in—and not in—the new healthcare legislation signed into law by President Barack Obama in March? You're not alone. More than 2,100 adults were given a list of 18 reform items and asked to identify what's included and what's not included in the law. Only four items were correctly identified by the majority of those polled.

31 Jul 2010

Water Street Healthcare Partners acquires Medical Specialties Distributors

Water Street Healthcare Partners, a leading private equity firm focused exclusively on health care, announced today that it has acquired Medical Specialties Distributors, LLC (MSD). Headquartered in Stoughton, Massachusetts, MSD is the nation's leading provider of infusion products, supplies, biomedical services and technology solutions to the growing home infusion therapy market. The acquisition expands Water Street's current group of health care companies to 12.

From Baxter International Inc. 31 Jul 2010

QPharma releases qSpend Web-based aggregate spend solution

QPharma, Inc., the industry leader in FDA Regulatory and Compliance Solutions, announced today the official release of their aggregate spend solution, qSpend. This tool assists Pharmaceutical, Biotechnology, and Medical Device companies in complying with countless state and federal laws, regulations, and industry guidelines governing sales and marketing. qSpend is QPharma's cost-efficient, aggregate spend solution for tracking, evaluating, and reporting sales and marketing expenditures in a regulatory compliant manner.

31 Jul 2010

Microsulis launches Acculis percutaneous microwave tissue ablation system at ECIO

Microsulis Medical Ltd (MML), the leading company in microwave technology for medical devices, has successfully launched the Acculis percutaneous microwave tissue ablation system, Accu2i pMTA, at the second European Conference on Interventional Oncology (ECIO) in Florence, Italy. A revolutionary new device for destroying tumours, the system is a 1.8mm diameter closed water-cooled needle, with performance matching the existing Acculis open surgery MTA system.

31 Jul 2010

FDA clears ZOLL's new Propaq MD Monitor/Defibrillator

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market and begin distribution of the new Propaq® MD Monitor/Defibrillator that was developed specifically to meet the special needs of military customers and air medical operations worldwide. Development of this product was a joint undertaking between the Department of Defense and a cooperative arrangement between Welch Allyn and ZOLL.

30 Jul 2010

Down the silk road of the future

The Science paper notes that the development of silk hydrogels, films, fibers and sponges is making possible advances in photonics and optics, nanotechnology, electronics, adhesives and microfluidics, as well as engineering of bone and ligaments. Because silk fiber formation does not rely on complex or toxic chemistries, such materials are biologically and environmentally friendly, even able to integrate with living systems.

30 Jul 2010

CryoLife second-quarter revenues increase 4% to record $29.3 million

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today its results for the second quarter of 2010. Revenues for the second quarter increased 4 percent to a second quarter record of $29.3 million compared to $28.2 million for the second quarter of 2009. Net income for the second quarter of 2010 was $2.9 million, or $0.10 per basic and fully diluted common share, compared to $2.5 million, or $0.09 per basic and fully diluted common share, for the second quarter of 2009.

30 Jul 2010

USPTO grants IRIDEX patent for Adjustable Laser Probe for use in vitreoretinal surgery

IRIDEX Corporation today announced the receipt of an Issue Notification from the U.S. Patent and Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the IRIDEX product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser handpieces.

29 Jul 2010

ZOLL Medical receives PMDA approval to distribute AED Plus, AED Pro in Japan

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it has been granted approval by the Japanese Pharmaceutical and Medical Devices Agency to import and distribute the AED Plus and AED Pro in Japan.

29 Jul 2010